Ugrás a tartalomhoz

Tényeken Alapuló Orvostudomány Módszertani Ajánlások

Nyirkos Péter dr. (2005)

Melania Kiadói Kft.

Irodalom

Irodalom

ebm00722

  • [1]Mari JJ, Streiner D. Family intervention for schizophrenia. The Cochrane Database of Systematic Reviews, Cochrane Library number: CD000088. In: The Cochrane Library, Issue 2, 2002. Oxford: Update Software. Updated frequently.

  • [2]Jones C, Cormac I, Mota J, Campbell C. Cognitive behaviour therapy for schizophrenia. The Cochrane Database of Systematic Reviews, Cochrane Library number: CD000524. In: The Cochrane Library, Issue 3, 2002. Oxford: Update Software. Updated frequently.

  • [3]Tyler P, Coid J, Simmonds S, Joseph P, Marriott S. Community mental health teams (CMHT) for people with severe mental ilnesses and disordered personality. The Cochrane Database of Systematic Reviews, Cochrane Library number: CD000270. In: The Cochrane Library, Issue 2, 2002. Oxford: Update Software. Updated frequently.

  • [4]Waraich PS, Adams CE, Roque M, Hamill KM, Marti J. Haloperidol dose for the acute phase of schizophrenia. The Cochrane Database of Systematic Reviews, Cochrane Library number: CD003082. In: The Cochrane Library, Issue 3, 2002. Oxford: Update Software.

  • [5]Fenton M, Coutinho E, Campbell C. Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses. The Cochrane Database of Systematic Reviews, Cochrane Library number: CD000525. In: The Cochrane Library, Issue 2, 2002. Oxford: Update Software. Updated frequently.

  • [6]Thornley B, Adams CE, Awad G. Chlorpromazine versus placebo for schizophrenia. The Cochrane Database of Systematic Reviews, Cochrane Library number: CD000284. In: The Cochrane Library, Issue 2, 2002. Oxford: Update Software. Updated frequently.

  • [7]Barbui C, Saraceno B, Liberati A, Garattini S. Low-dose neuroleptic therapy and relapse in schizophrenia: meta-analysis of randomized controlled trials. European Psychiatry 1996;11:306-313.

  • [8]The Database of Abstracts of Reviews of Effectiveness (University of York), Database no.: DARE-961859. In: The Cochrane Library, Issue 4, 1999. Oxford: Update Software

  • [9]Bollini P, Pampallona S, Orza MJ, Adams MR, Chalmers TC. Antipsychotic drugs: Is more worse? A meta-analysis of the published randomized controlled trials. Psychological Medicine 1994;24:307-316.

  • [10]The Database of Abstracts of Reviews of Effectiveness (University of York), Database no.: DARE-940125. In: The Cochrane Library, Issue 4, 1999. Oxford: Update Software

  • [11]Kennedy F, Song F, Hunter R, Clark A, Gilbody S. Risperidone versus typical antipsychotic medication for schizophrenia. The Cochrane Database of Systematic Reviews, Cochrane Library number: CD000440. In: The Cochrane Library, Issue 3, 2002. Oxford: Update Software. Updated frequently.

  • [12]de Oliveira IR, Miranda-Scippa AM, de Sena EP, Pereira EL, Ribeiro MG, de Castro-e-Silva E, Bacaltchuk J. Risperidone versus haloperidol in the treatment of schizophrenia: a meta-analysis comparing their efficacy and safety. J Clin Pharmal Therap 1996;21:349-358

  • [13]The Database of Abstracts of Reviews of Effectiveness (University of York), Database no.: DARE-970218. In: The Cochrane Library, Issue 4, 1999. Oxford: Update Software

  • [14]Leucht S, Pitschel-Walz G, Abraham D, Kissling W. Efficacy and extrapyramidal side effects of the new antipsychotics olanzapine, quetiapine, risperidone and sertindole compared to conventional antipsychotis: a meta-analysis of randomized controlled trials. Schizophrenia Research 1999;35:51-68

  • [15]The Database of Abstracts of Reviews of Effectiveness (University of York), Database no.: DARE-993710. In: The Cochrane Library, Issue 2, 2001. Oxford: Update Software

  • [16]Lawrie S. Quetiapine in schizophrenia. Clinical Evidence 2000;4:564-565

  • [17]Koro CE, Fedder DO, L talien GJ, Weiss SS, Magder LS, Kreyenbuhl J et al. Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study. BMJ 2002;325:243.

  • [18]Wahlbeck K, Cheine M, Essali MA. Clozapine versus typical neuroleptic medication for schizophrenia. The Cochrane Database of Systematic Reviews, Cochrane Library number: CD000059. In: The Cochrane Library, Issue 3, 2002. Oxford: Update Software. Updated frequently

  • [19]Newer atypical antipsychotic medication in comparison to clozapine: a systematic review of randomized trials. Tuunainen A, Wahlbeck K, Gilbody S. Schizophr Res 2002;56:1-10.

  • [20]Duggan L, Fenton M, Dardennes RM, El-Dosoky A, Indran S. Olanzapine for schizophrenia. The Cochrane Database of Systematic Reviews, Cochrane Library number: CD001359. In: The Cochrane Library, Issue 2, 2002. Oxford: Update Software. Updated frequently.

  • [21]Sultana A, Reilly J, Fenton M. Thioridazine for schizophrenia. The Cochrane Database of Systematic Reviews, Cochrane Library number: CD001944. In: The Cochrane Library, Issue 3, 2002. Oxford: Update Software. Updated frequently

  • [22]Glassman AH, Bigger JT Jr. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 2001;158:1774-82.

  • [23]Quraishi S, David A. Depot haloperidol decanoate for schizophrenia. The Cochrane Database of Systematic Reviews, Cochrane Library number: CD001361. In: The Cochrane Library, Issue 3, 2002. Oxford: Update Software. Updated frequently

  • [24]Quraishi S, David A. Depot flupenthixol decanoate for schizophrenia or other similar psychotic disorders. The Cochrane Database of Systematic Reviews, Cochrane Library number: CD001470. In: The Cochrane Library, Issue 3, 2002. Oxford: Update Software. Updated frequently.

  • [25]Lawrie S. Continued treatment with antipsychotic drugs in schizophrenia. Clinical Evidence 2000;4:568-569

  • [26]Tharyan P. Electroconvulsive therapy for schizophrenia. The Cochrane Database of Systematic Reviews, Cochrane Library number: CD000076. In: The Cochrane Library, Issue 3, 2002. Oxford: Update Software. Updated frequently.

  • [27]Gilbody SM, Bagnall AM, Duggan L, Tuunainen A. Risperidone versus other atypical antipsychotic medication for schizophrenia. The Cochrane Database of Systematic Reviews, Cochrane Library number: CD002306. In: The Cochrane Library, Issue 3, 2002. Oxford: Update Software. Updated frequently

  • [28]Lawrie S. Quetiapine in schizophrenia. Clinical Evidence 2000;4:564-565

  • [29]Pekkala E, Merinder L. Psychoeducation in schizophrenia. The Cochrane Database of Systematic Reviews, Cochrane Library number: CD002831. In: The Cochrane Library, Issue 3, 2002. Oxford: Update Software. Updated frequently

  • [30]Joy CB, Adams CE, Rice K. Crisis intervention for people with severe mental illnesses. The Cochrane Database of Systematic Reviews, Cochrane Library number: CD001087. In: The Cochrane Library, Issue 3, 2002. Oxford: Update Software. Updated frequently.

  • [31]Bond GR, Drake RE, Mueser KT, Becker DR. An update on supported employment for people with severe mental illness. Psychiatric Services 1997;48:335-346

  • [32]The Database of Abstracts of Reviews of Effectiveness (University of York), Database no.: DARE-970407. In: The Cochrane Library, Issue 4, 1999. Oxford: Update Software

  • [33]Catty J, Burns T, Comas A. Day centres for severe mental illness. The Cochrane Database of Systematic Reviews, Cochrane Library number: CD001710. In: The Cochrane Library, Issue 3, 2002. Oxford: Update Software. Updated frequently

  • [34]Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ. Antipsychotic-induced weight gain: a comprehensive research synthesis. American Journal of Psychiatry 1999;156:1686-1696

  • [35]The Database of Abstracts of Reviews of Effectiveness (University of York), Database no.: DARE-992233. In: The Cochrane Library, Issue 2, 2001. Oxford: Update Software